The FDA has accepted Eli Lilly's regulatory submission for orforglipron in obesity, with a target action date of April 10, 2026, under the Commissioner's National Priority Review Voucher program
Since allulose does not significantly raise blood glucose levels, it can be a beneficial sweetener option for those with Type 1 diabetes who need to carefully manage their carbohydrate intake
Common sources include: Ketchup Barbecue sauce Sweet chilli sauce Honey mustard Sweet salad dressings Chocolate spreads Healthier swap: Fresh herbs, lemon juice, Greek yogurt-based dips, hummus, pesto, or olive oil with vinegar
In general, get information from a doctor as opposed to online
Patient has a BMI (body mass index) of 27 or higher and at least one weight-related health condition like diabetes, high blood pressure, heart disease, or sleep apnea
45 In that trial, patients receiving semaglutide experienced greater reductions in weight (estimated difference 10.7%